These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1960784)

  • 1. Blood transfusions and phenotypic immune profile in head and neck cancer patients undergoing surgical resection.
    MacRae JD; Lampe H; Banerjee D
    J Otolaryngol; 1991 Oct; 20(5):310-4. PubMed ID: 1960784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival.
    Kwon AH; Matsui Y; Kamiyama Y
    Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
    Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
    Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of poor CD3 response in head and neck cancer.
    Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
    Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma.
    Brivio F; Lissoni P; Redaelli R; Maggioni A; Rovelli F; Rescaldani R; Borin F; Erba L; Alderi G
    Minerva Chir; 1993 Apr; 48(7):331-5. PubMed ID: 8327179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma.
    Taniguchi Y; Okura M
    Head Neck; 2003 Nov; 25(11):931-6. PubMed ID: 14603453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
    Sun CF; Hsieh YY; Ngan KW; Wang WT
    Ann Clin Lab Sci; 2001 Apr; 31(2):171-8. PubMed ID: 11337907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total lymphocyte and T lymphocyte subpopulation levels in head and neck squamous cell carcinomas.
    Soysal V; Yigitbasi OG; Alper M; Patiroglu T; Güney E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):207-12. PubMed ID: 9700582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
    Dawson DE; Everts EC; Vetto RM; Burger DR
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):342-5. PubMed ID: 3875306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
    Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
    Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Olofsson J
    Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.
    Saito T; Kuss I; Dworacki G; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 1999 Jun; 5(6):1263-73. PubMed ID: 10389908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.